Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
Neoplasma. 2010;57(3):215-21. doi: 10.4149/neo_2010_03_215.
Telomere length was evaluated by terminal repeat fragment method in 66 previously untreated patients with B-chronic lymphocytic leukemia (B-CLL) to ascertain whether telomere shortening was associated with genomic aberrations, immunoglobulin variable heavy chain (IgVH) mutational status, CD38 and ZAP-70 expression, and telomerase activity. Chromosomal aberrations were present in peripheral blood cells of 73% patients (48/66), no difference in telomere length between patients with good and intermediate prognosis according to cytogenetics was found. Association between telomere length and IgVH mutational status, ZAP-70 and CD38 expression was proved as significantly shorter telomeres in patients with unmutated IgVH status (p=0.01) and ZAP-70 positivity (p=0.01) and CD38 positivity (p=0.05) were detected. Telomerase activity was positive in 11 patients out of 21 examined, correlation between telomere length and telomerase activity was found (p=0.05). Telomere length and telomerase activity in combination with other prognostic parameters complete the risk profile of B-CLL patients and might serve for an easy decision on optimal treatment strategy.
B-chronic lymphocytic leukemia, telomere length, telomerase activity, chromosomal aberrations, prognosis.
通过端重复片段法评估了 66 例未经治疗的 B 慢性淋巴细胞白血病(B-CLL)患者的端粒长度,以确定端粒缩短是否与基因组异常、免疫球蛋白重链可变区(IgVH)突变状态、CD38 和 ZAP-70 表达以及端粒酶活性有关。73%的患者(48/66)在外周血细胞中存在染色体异常,根据细胞遗传学,具有良好和中等预后的患者之间的端粒长度没有差异。端粒长度与 IgVH 突变状态、ZAP-70 和 CD38 表达之间的关联被证明为未突变 IgVH 状态(p=0.01)和 ZAP-70 阳性(p=0.01)以及 CD38 阳性(p=0.05)患者的端粒较短。在 21 例检查的患者中,有 11 例端粒酶活性为阳性,发现端粒长度与端粒酶活性之间存在相关性(p=0.05)。端粒长度和端粒酶活性与其他预后参数相结合,可完善 B-CLL 患者的风险概况,并有助于为最佳治疗策略做出简单决策。
B 慢性淋巴细胞白血病,端粒长度,端粒酶活性,染色体异常,预后。